{
  "guideline": {
    "id": "PA166328716",
    "name": "FDA PGx Association [Pharmacogenetic Associations for which the Data Support Therapeutic Management Recommendations]: Tramadol - CYP2D6",
    "objCls": "PGx Association",
    "source": "FDA",
    "version": 0,
    "url": "https://www.pharmgkb.org/fdaPgxAssociations#PA166328716",
    "relatedChemicals": [
      {
        "id": "PA451735",
        "name": "tramadol",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166311223",
      "name": "Recommendation Annotation PA166311223",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214462,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311243",
      "name": "Recommendation Annotation PA166311243",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214482,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311227",
      "name": "Recommendation Annotation PA166311227",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214467,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311225",
      "name": "Recommendation Annotation PA166311225",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214464,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311242",
      "name": "Recommendation Annotation PA166311242",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214481,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311222",
      "name": "Recommendation Annotation PA166311222",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214461,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311226",
      "name": "Recommendation Annotation PA166311226",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214465,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311224",
      "name": "Recommendation Annotation PA166311224",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214463,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311261",
      "name": "Recommendation Annotation PA166311261",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214500,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥6.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311228",
      "name": "Recommendation Annotation PA166311228",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214468,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥5.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311241",
      "name": "Recommendation Annotation PA166311241",
      "population": "Affected subgroup: CYP2D6 ultrarapid metabolizers",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA451735",
          "name": "tramadol",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452214480,
        "html": "<p>&quot;Results in higher systemic and breast milk active metabolite concentrations, which may result in respiratory depression and death. Contraindicated in children under 12 and in adolescents following tonsillectomy/adenoidectomy. Breastfeeding is not recommended during treatment.&quot;</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [],
  "version": "2024-03-08-14-34"
}